{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:28:15Z","timestamp":1790832495362,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.seizure.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:30:24Z","timestamp":1498311024000},"page":"166-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Management of epilepsy in MERRF syndrome"],"prefix":"10.1016","volume":"50","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinda","family":"Zarrouk-Mahjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2017.06.010_bib0005","series-title":"GeneReviews\u00ae [Internet]","article-title":"MERRF","author":"DiMauro","year":"2003"},{"key":"10.1016\/j.seizure.2017.06.010_bib0010","article-title":"Psoriasis, hyperlipidemia, bulbar involvement, and diarrhoea in MERRF-syndrome due to the m.8344A>G tRNA(Lys) mutation","author":"Finsterer","year":"2017","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11011-013-9464-5","article-title":"MERRF\/MELAS overlap syndrome due to the m.3291T>C mutation","volume":"29","author":"Liu","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.seizure.2017.06.010_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00431-011-1662-8","article-title":"Classical MERRF phenotype associated with mitochondrial tRNA(Leu) (m.3243A>G) mutation","volume":"171","author":"Brackmann","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.seizure.2017.06.010_bib0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0031-1283167","article-title":"MERRF-like phenotype associated with a rare mitochondrial trnaile mutation (m.4284 G>A)","volume":"42","author":"Hahn","year":"2011","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.seizure.2017.06.010_bib0030","doi-asserted-by":"crossref","first-page":"15299","DOI":"10.1073\/pnas.0704441104","article-title":"Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome","volume":"104","author":"Ling","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.seizure.2017.06.010_bib0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archneurol.2008.576","article-title":"A new mitochondrial transfer RNAPro gene mutation associated with myoclonic epilepsy with ragged-red fibers and other neurological features","volume":"66","author":"Blakely","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0040","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.braindev.2012.08.006","article-title":"Late-onset Leigh syndrome with myoclonic epilepsy with ragged-red fibers","volume":"35","author":"Monden","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2017.06.010_bib0045","first-page":"1051","article-title":"Seizures in myoclonic epilepsy with ragged-red fibers detected by DNA analysis: a case report","volume":"84","author":"Sitburana","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.seizure.2017.06.010_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.1575","article-title":"Advances in the genetics of progressive myoclonus epilepsy","volume":"106","author":"Delgado-Escueta","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.seizure.2017.06.010_bib0055","first-page":"1198","article-title":"Two cases of MERRF (myoclonus epilepsy associated with ragged red fibers) showing different clinical features in the same family","volume":"33","author":"Nomura","year":"1993","journal-title":"Rinsho Shinkeigaku"},{"issue":"Suppl. 4","key":"10.1016\/j.seizure.2017.06.010_bib0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1528-1167.2012.03618.x","article-title":"Mitochondrial diseases and epilepsy","volume":"53","author":"Bindoff","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.06.010_bib0065","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/112.5.1231","article-title":"Myoclonus epilepsy and ragged-red fibres (MERRF) 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study","volume":"112","author":"Berkovic","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.seizure.2017.06.010_bib0070","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mds.25839","article-title":"Myoclonus in mitochondrial disorders","volume":"29","author":"Mancuso","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ana.24525","article-title":"Epilepsy in adults with mitochondrial disease: a cohort study","volume":"78","author":"Whittaker","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0035-1552624","article-title":"Mitochondrial causes of epilepsy: evaluation, diagnosis, and treatment","volume":"35","author":"Steele","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yebeh.2014.08.134","article-title":"Metabolic and mitochondrial disorders associated with epilepsy in children with autism spectrum disorder","volume":"47","author":"Frye","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2017.06.010_bib0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ane.12122","article-title":"Mitochondrial epilepsy in pediatric and adult patients","volume":"128","author":"Finsterer","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2017.06.010_bib0095","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.seizure.2012.03.003","article-title":"Epilepsy in mitochondrial disorders","volume":"21","author":"Finsterer","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.06.010_bib0100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/epd.2016.0846","article-title":"Myoclonus epilepsy in mitochondrial disorders","volume":"18","author":"Lamperti","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1684\/epd.2016.0861","article-title":"Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials","volume":"18","author":"Michelucci","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425255.2012.644535","article-title":"Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders","volume":"8","author":"Finsterer","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0115","first-page":"336","article-title":"Activities of respiratory chain complexes and citrate synthase influenced by pharmacologically different antidepressants and mood stabilizers","volume":"31","author":"Hroudova","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.seizure.2017.06.010_bib0120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0006-2952(92)90590-F","article-title":"Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration","volume":"43","author":"Ponchaut","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0125","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.tiv.2008.03.004","article-title":"Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver","volume":"22","author":"Santos","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.seizure.2017.06.010_bib0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1995.tb01615.x","article-title":"Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-l-tryptophan","volume":"36","author":"Pranzatelli","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.06.010_bib0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2013.05.013","article-title":"Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2)","volume":"17","author":"Scalais","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0140","first-page":"399","article-title":"A8344G mutation of the mitochondrial DNA with typical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome","volume":"64","author":"Vastagh","year":"2011","journal-title":"Ideggyogy Sz"},{"key":"10.1016\/j.seizure.2017.06.010_bib0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejpn.2016.08.002","article-title":"Stroke-like episodes, peri-episodic seizures, and MELAS mutations","volume":"20","author":"Finsterer","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.seizure.2013.03.003","article-title":"Mutation in the mitochondrial tRNA(Ile) gene causes progressive myoclonus epilepsy","volume":"22","author":"Zsurka","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.06.010_bib0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jfma.2013.02.008","article-title":"Neuroimaging and electroencephalographic changes after vagus nerve stimulation in a boy with medically intractable myoclonic astatic epilepsy","volume":"113","author":"Fan","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.seizure.2017.06.010_bib0160","first-page":"S0887","article-title":"Epilepsy characteristics and clinical outcome in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)","author":"Lee","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0165","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA MERRF mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.06.010_bib0170","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00415-014-7632-0","article-title":"Myo-cardiomyopathy is commonly associated with the A8344G MERRF mutation","volume":"262","author":"Catteruccia","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0175","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.mito.2011.01.003","article-title":"MERRF: clinical features, muscle biopsy and molecular genetics in Brazilian patients","volume":"11","author":"Lorenzoni","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.seizure.2017.06.010_bib0180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00415-009-0841-2","article-title":"The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders","volume":"256","author":"Molnar","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2007.10.001","article-title":"The mtDNA A8344G MERRF mutation is not a common cause of sporadic Parkinson disease in Italian population","volume":"14","author":"Mancuso","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000250334.48038.7a","article-title":"Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys","volume":"68","author":"Horvath","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.06.010_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00415-009-0921-3","article-title":"A8344G tRNALys mutation associated with recurrent brain stem stroke-like episodes","volume":"256","author":"Zaganas","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0200","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.3174\/ajnr.A2182","article-title":"Cavitating leukoencephalopathy in a child carrying the mitochondrial A8344G mutation","volume":"31","author":"Biancheri","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0205","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.pediatrneurol.2014.08.020","article-title":"Symmetric thalamic lesions in a patient with a myoclonic epilepsy with ragged red fibers-Leigh spectrum phenotype due to the m.A8344G mutation","volume":"51","author":"Yang","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0210","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00415-016-8086-3","article-title":"Expanded phenotypic spectrum of the m.8344A>G MERRF mutation: data from the German mitoNET registry","volume":"263","author":"Altmann","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0215","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/j.1468-1331.2007.01926.x","article-title":"Infantile presentation of the mitochondrial A8344G mutation","volume":"14","author":"Scalais","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0220","first-page":"217","article-title":"Clinical features and genetics of myoclonic epilepsy with ragged red fibers","volume":"89","author":"DiMauro","year":"2002","journal-title":"Adv Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0225","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nmd.2014.03.011","article-title":"Distal weakness with respiratory insufficiency caused by the m.8344A>G MERRF mutation","volume":"24","author":"Blakely","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0230","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1590\/0004-282X20140124","article-title":"When should MERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis","volume":"72","author":"Lorenzoni","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.seizure.2017.06.010_bib0235","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clineuro.2008.06.010","article-title":"Unusual presentations of patients with the mitochondrial MERRF mutation A8344G","volume":"110","author":"Wiedemann","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.seizure.2017.06.010_bib0240","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1177\/0883073808318541","article-title":"Fibrous dysplasia in a child with mitochondrial A8344G mutation","volume":"23","author":"Chen","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0245","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181d0ccf4","article-title":"Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA","volume":"74","author":"Wahbi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.06.010_bib0250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0960-8966(00)00176-0","article-title":"A case of MERRF associated with chronic pancreatitis","volume":"11","author":"Toyono","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.seizure.2017.06.010_bib0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-002-0604-y","article-title":"The A8344G mutation in mitochondrial DNA associated with stroke-like episodes and gastrointestinal dysfunction","volume":"105","author":"Tanji","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0260","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N","article-title":"The MERRF mutation of mitochondrial DNA in the bone marrow of a patient with acquired idiopathic sideroblastic anemia","volume":"60","author":"Wang","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0265","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/WNL.51.5.1447","article-title":"Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation","volume":"51","author":"Austin","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.06.010_bib0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1460-9592.2005.01384.x","article-title":"Anesthetic management of a patient with MERRF syndrome","volume":"15","author":"Vilela","year":"2005","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.seizure.2017.06.010_bib0275","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11940-011-0131-z","article-title":"Treatment options in juvenile myoclonic epilepsy","volume":"13","author":"Mantoan","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0280","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1528-1167.2007.01186.x","article-title":"Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia","volume":"48","author":"Kilaru","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2017.06.010_bib0285","first-page":"870","article-title":"Myoclonus epilepsy associated with ragged-red fibers\u2013report of a patient with negative myoclonus","volume":"32","author":"Iwanga","year":"1992","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.seizure.2017.06.010_bib0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000110193.78872.DD","article-title":"Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients","volume":"62","author":"Crest","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2017.06.010_bib0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2005.11.021","article-title":"Antimyoclonic effect of levetiracetam in MERRF syndrome","volume":"243","author":"Mancuso","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.seizure.2017.06.010_bib0300","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pediatrneurol.2010.02.013","article-title":"Efficacy of felbamate in the treatment of intractable pediatric epilepsy","volume":"42","author":"Zupanc","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0305","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.seizure.2011.12.010","article-title":"Lacosamide treatment of juvenile myoclonic epilepsy","volume":"21","author":"Afra","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2017.06.010_bib0310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejpn.2011.12.012","article-title":"First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome)","volume":"16","author":"von St\u00fclpnagel","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2017.06.010_bib0315","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebcr.2015.06.007","article-title":"Use of perampanel in one case of super-refractory hypoxic myoclonic status: case report","volume":"4","author":"Santamarina","year":"2015","journal-title":"Epilepsy Behav Case Rep"},{"key":"10.1016\/j.seizure.2017.06.010_bib0320","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archneur.58.5.781","article-title":"Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy","volume":"58","author":"Fedi","year":"2001","journal-title":"Arch Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131117301243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:49:28Z","timestamp":1761011368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131117301243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":64,"alternative-id":["S1059131117301243"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2017.06.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of epilepsy in MERRF syndrome","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}